Trademark: 87771487
Word
NOVAGO
Status
Registered
Status Code
700
Status Date
Tuesday, October 8, 2019
Serial Number
87771487
Registration Number
5877137
Registration Date
Tuesday, October 8, 2019
Mark Type
4000
Filing Date
Friday, January 26, 2018
Published for Opposition
Tuesday, July 23, 2019

Trademark Owner History
NovaGo Therapeutics AG - Original Registrant

Classifications
5 Pharmaceutical preparations, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; veterinary preparations, namely, for the regenerative treatment of disorders, including, but not limited to, central nervous system, eye, skin and other; preparations for immunotherapeutic purposes, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; products for the removal of tumors, namely preparations for neurodegenerative diseases, namely, but not limited to, traumatic brain injury, spinal cord injury, stroke; immunogens for medical use, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; vaccines, antibodies, epitopes for pharmaceutical use; peptides for pharmaceutical purposes; sanitary preparations for medical use for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; biological preparations for medical use for the treatment of neurological, ophthalmic, skin disorders; biocides; diagnostic products, namely, for the development of new therapeutic agents; towels for hygiene purposes, namely, sanitary towels; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposes, namely, for the regenerative treatment of disorders, including, but not limited to, central nervous system, eye, skin and other disorders
1 Chemical products, namely, for the regenerative treatment of disorders affecting human beings, including but not limited to, central nervous system, eye, skin and other disorders; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes, namely, biological monoclonal antibodies and formulations for human therapeutic use; biological preparations for use in industry and science; peptides for chemical products and foodstuffs in the nature of biological monoclonal antibodies and formulations for human therapeutic use; polypeptides; antibodies and proteins for scientific use
44 Medical services; medical services in the field of immunity; provision of medical information; medical examinations, namely, assessments used for clinical research purposes; dispensing of pharmaceuticals; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care; veterinary assistance in the nature of veterinary services, namely, assessments and procedures that leads to novel pharmaceutical products; beauty salon services; care services for animals, namely, for the regenerative treatment of veterinary trauma disorders; hygienic care; consultancy and provision of information relating to the operation, preparation, administration and dosage of pharmaceutical preparations
42 Monitoring of degenerative and traumatic disorders affecting human beings for quality control purposes; Research in the field of regenerative treatment of degenerative or traumatic human disorders research in the field of sanitary care; computer software design, computer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparations, namely, preparations for regenerative treatment of human disorders; software maintenance

Trademark Events
Nov 10, 2023
Teas Change Of Correspondence Received
Nov 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 21, 2021
Teas Change Of Correspondence Received
Jul 21, 2021
Teas Change Of Domestic Representatives Address
Jul 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 8, 2019
Registered-Principal Register
Jul 23, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Published For Opposition
Jul 3, 2019
Notification Of Notice Of Publication E-Mailed
Jun 18, 2019
Electronic Record Review Complete
Jun 14, 2019
On Hold - Electronic Record Review Required
Jun 11, 2019
Approved For Pub - Principal Register
Jun 10, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 10, 2019
Teas Change Of Owner Address Received
Jun 10, 2019
Teas/Email Correspondence Entered
Jun 10, 2019
Correspondence Received In Law Office
Jun 10, 2019
Teas Response To Office Action Received
Jan 10, 2019
Notification Of Priority Action E-Mailed
Jan 10, 2019
Priority Action E-Mailed
Jan 10, 2019
Priority Action Written
Dec 12, 2018
Teas/Email Correspondence Entered
Dec 12, 2018
Correspondence Received In Law Office
Dec 12, 2018
Assigned To Lie
Dec 6, 2018
Teas Response To Suspension Inquiry Received
Nov 29, 2018
Notification Of Letter Of Suspension E-Mailed
Nov 29, 2018
Letter Of Suspension E-Mailed
Nov 29, 2018
Suspension Letter Written
Nov 8, 2018
Teas/Email Correspondence Entered
Nov 8, 2018
Correspondence Received In Law Office
Nov 8, 2018
Teas Response To Office Action Received
May 14, 2018
Notification Of Non-Final Action E-Mailed
May 14, 2018
Non-Final Action E-Mailed
May 14, 2018
Non-Final Action Written
May 9, 2018
Assigned To Examiner
Feb 7, 2018
New Application Office Supplied Data Entered
Jan 30, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24